• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

E2F 转录因子 1 通过抑制 microRNA-107 的转录来提高 cyclin D1 的表达,从而促进神经胶质瘤的进展。

E2F transcription factor 1 elevates cyclin D1 expression by suppressing transcription of microRNA-107 to augment progression of glioma.

机构信息

Department of Clinical Medicine, Jiangxi Health Vocational College, Nanchang, P. R. China.

Department of Neurosurgery, The Second Affiliated Hospital of Nanchang University, Nanchang, P. R. China.

出版信息

Brain Behav. 2021 Dec;11(12):e2399. doi: 10.1002/brb3.2399. Epub 2021 Nov 10.

DOI:10.1002/brb3.2399
PMID:34758200
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8671784/
Abstract

BACKGROUND

Dysregulation of microRNAs has been frequently implicated in the progression of human diseases, including glioma. This study aims to explore the interaction between E2F transcription factor 1 (E2F1) and miR-107 in the progression of glioma.

METHODS

Expression of miR-107 in glioma tissues and cells was examined. Putative binding sites between E2F1 and the promoter region of miR-107, and between miR-107 and cyclin D1 (CCND1) mRNA were predicted via bioinformatic systems and validated via chromatin immunoprecipitation and luciferase reporter gene assays. Altered expression of miR-107, E2F1, and CCND1 was introduced in A172 and T98G cells to examine their roles in cell growth and the activity of the Wnt/β-catenin signaling. In vivo experiments were performed by injecting cells in nude mice.

RESULTS

miR-107 was poorly expressed, whereas E2F1 and CCND1 were highly expressed in glioma tissues and cells. E2F1 bound to the promoter region of miR-107 to induce transcriptional repression, and miR-107 directly bound to CCND1 mRNA to reduce its expression. Overexpression of miR-107 reduced proliferation, migration and invasion, and augmented apoptosis of glioma cells, and it reduced activity of the Wnt/β-catenin pathway. The anti-tumorigenic roles of miR-107 were blocked by E2F1 or CCND1 overexpression. Similar results were reproduced in vivo where miR-107 overexpression or E2F1 inhibition blocked tumor growth in nude mice.

CONCLUSION

This study suggested that E2F1 reduces miR-107 transcription to induce CCND1 upregulation, which leads to progression of glioma via Wnt/β-catenin signaling activation.

摘要

背景

microRNAs 的失调经常与包括神经胶质瘤在内的人类疾病的进展有关。本研究旨在探讨 E2F 转录因子 1(E2F1)与 miR-107 在神经胶质瘤进展中的相互作用。

方法

检测 miR-107 在神经胶质瘤组织和细胞中的表达。通过生物信息学系统预测 E2F1 与 miR-107 启动子区域之间以及 miR-107 与细胞周期蛋白 D1(CCND1)mRNA 之间的假定结合位点,并通过染色质免疫沉淀和荧光素酶报告基因检测进行验证。在 A172 和 T98G 细胞中改变 miR-107、E2F1 和 CCND1 的表达,以研究它们在细胞生长和 Wnt/β-catenin 信号通路活性中的作用。通过向裸鼠注射细胞进行体内实验。

结果

miR-107 在神经胶质瘤组织和细胞中表达水平较低,而 E2F1 和 CCND1 表达水平较高。E2F1 结合到 miR-107 的启动子区域,诱导转录抑制,miR-107 直接结合到 CCND1 mRNA 上,降低其表达。miR-107 的过表达减少了神经胶质瘤细胞的增殖、迁移和侵袭,并促进了细胞凋亡,同时降低了 Wnt/β-catenin 通路的活性。E2F1 或 CCND1 的过表达阻断了 miR-107 的抗肿瘤作用。在体内实验中也得到了类似的结果,miR-107 的过表达或 E2F1 的抑制阻断了裸鼠肿瘤的生长。

结论

本研究表明,E2F1 降低 miR-107 的转录以诱导 CCND1 的上调,从而通过 Wnt/β-catenin 信号通路的激活导致神经胶质瘤的进展。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/365c32f4e252/BRB3-11-e2399-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/e30b24db8282/BRB3-11-e2399-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/82e7d76d2ff0/BRB3-11-e2399-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/db81ea51954b/BRB3-11-e2399-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/8ba65ed0163c/BRB3-11-e2399-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/44a77a8e522a/BRB3-11-e2399-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/c6120edb561c/BRB3-11-e2399-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/365c32f4e252/BRB3-11-e2399-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/e30b24db8282/BRB3-11-e2399-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/82e7d76d2ff0/BRB3-11-e2399-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/db81ea51954b/BRB3-11-e2399-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/8ba65ed0163c/BRB3-11-e2399-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/44a77a8e522a/BRB3-11-e2399-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/c6120edb561c/BRB3-11-e2399-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0bca/8671784/365c32f4e252/BRB3-11-e2399-g004.jpg

相似文献

1
E2F transcription factor 1 elevates cyclin D1 expression by suppressing transcription of microRNA-107 to augment progression of glioma.E2F 转录因子 1 通过抑制 microRNA-107 的转录来提高 cyclin D1 的表达,从而促进神经胶质瘤的进展。
Brain Behav. 2021 Dec;11(12):e2399. doi: 10.1002/brb3.2399. Epub 2021 Nov 10.
2
Long noncoding RNA OIP5-AS1 targets Wnt-7b to affect glioma progression via modulation of miR-410.长链非编码 RNA OIP5-AS1 通过调节 miR-410 靶向 Wnt-7b 影响胶质瘤的进展。
Biosci Rep. 2019 Jan 3;39(1). doi: 10.1042/BSR20180395. Print 2019 Jan 31.
3
miR-218 suppresses gastric cancer cell cycle progression through the CDK6/Cyclin D1/E2F1 axis in a feedback loop.微小RNA-218通过CDK6/细胞周期蛋白D1/E2F1轴以反馈环的形式抑制胃癌细胞周期进程。
Cancer Lett. 2017 Sep 10;403:175-185. doi: 10.1016/j.canlet.2017.06.006. Epub 2017 Jun 17.
4
MicroRNA-383 inhibits anchorage-independent growth and induces cell cycle arrest of glioma cells by targeting CCND1.微小RNA-383通过靶向细胞周期蛋白D1抑制胶质瘤细胞的非锚定依赖性生长并诱导细胞周期停滞。
Biochem Biophys Res Commun. 2014 Oct 31;453(4):833-8. doi: 10.1016/j.bbrc.2014.10.047. Epub 2014 Oct 17.
5
E2F transcription factor 1/small nucleolar RNA host gene 18/microRNA-338-5p/forkhead box D1: an important regulatory axis in glioma progression.E2F 转录因子 1/小核仁 RNA 宿主基因 18/miRNA-338-5p/叉头框蛋白 D1:胶质瘤进展中的重要调控轴。
Bioengineered. 2022 Jan;13(1):418-430. doi: 10.1080/21655979.2021.2005990.
6
MicroRNA-551b-3p inhibits tumour growth of human cholangiocarcinoma by targeting Cyclin D1.MicroRNA-551b-3p 通过靶向细胞周期蛋白 D1 抑制人胆管癌的肿瘤生长。
J Cell Mol Med. 2019 Aug;23(8):4945-4954. doi: 10.1111/jcmm.14312. Epub 2019 Jun 14.
7
MiR-93 suppresses tumorigenesis and enhances chemosensitivity of breast cancer via dual targeting E2F1 and CCND1.miR-93 通过双重靶向 E2F1 和 CCND1 抑制乳腺癌的肿瘤发生和增强化疗敏感性。
Cell Death Dis. 2020 Aug 14;11(8):618. doi: 10.1038/s41419-020-02855-6.
8
MicroRNA-490-5P Targets CCND1 to Suppress Cellular Proliferation in Glioma Cells and Tissue Through Cell Cycle Arrest.微小RNA-490-5P靶向细胞周期蛋白D1,通过细胞周期阻滞抑制胶质瘤细胞和组织中的细胞增殖。
Curr Neurovasc Res. 2018;15(3):246-255. doi: 10.2174/1567202615666180813130143.
9
EIF4A3-induced circCCNB1 (hsa_circ_0001495) promotes glioma progression by elevating CCND1 through interacting miR-516b-5p and HuR.EIF4A3 诱导的 circCCNB1(hsa_circ_0001495)通过与 miR-516b-5p 和 HuR 相互作用来升高 CCND1 从而促进神经胶质瘤的进展。
Metab Brain Dis. 2022 Mar;37(3):819-833. doi: 10.1007/s11011-021-00899-x. Epub 2022 Jan 17.
10
MiR-15b targets cyclin D1 to regulate proliferation and apoptosis in glioma cells.微小RNA-15b靶向细胞周期蛋白D1以调节胶质瘤细胞的增殖和凋亡。
Biomed Res Int. 2014;2014:687826. doi: 10.1155/2014/687826. Epub 2014 Jun 4.

引用本文的文献

1
TP53 and EGFR amplification are negative predictors of overall survival in patients diagnosed with non-small cell lung cancer with brain metastases.TP53和表皮生长因子受体(EGFR)扩增是诊断为伴有脑转移的非小细胞肺癌患者总生存期的阴性预测指标。
Heliyon. 2024 Aug 19;10(16):e36532. doi: 10.1016/j.heliyon.2024.e36532. eCollection 2024 Aug 30.
2
Multiomics analyses reveal /YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance.多组学分析揭示了/YBX1 控制的转录后回路促进胶质母细胞瘤发生/放射抵抗。
Sci Adv. 2023 Aug 4;9(31):eadf3984. doi: 10.1126/sciadv.adf3984.
3
High expression of miR-107 and miR-17 predicts poor prognosis and guides treatment selection in acute myeloid leukemia.

本文引用的文献

1
Reprogramming of microRNA expression via E2F1 downregulation promotes Salmonella infection both in infected and bystander cells.通过下调 E2F1 实现 microRNA 表达重编程可促进感染细胞和旁观者细胞中的沙门氏菌感染。
Nat Commun. 2021 Jun 7;12(1):3392. doi: 10.1038/s41467-021-23593-z.
2
Long non-coding RNA FEZF1-AS1 promotes the proliferation and metastasis of hepatocellular carcinoma via targeting miR-107/Wnt/β-catenin axis.长链非编码 RNA FEZF1-AS1 通过靶向 miR-107/Wnt/β-catenin 轴促进肝癌的增殖和转移。
Aging (Albany NY). 2021 May 23;13(10):13726-13738. doi: 10.18632/aging.202960.
3
HOMER3 facilitates growth factor-mediated β-Catenin tyrosine phosphorylation and activation to promote metastasis in triple negative breast cancer.
miR-107和miR-17的高表达预示急性髓系白血病预后不良并指导治疗选择。
Transl Cancer Res. 2023 Apr 28;12(4):913-927. doi: 10.21037/tcr-22-2484. Epub 2023 Mar 17.
HOMER3 通过促进β-连环蛋白酪氨酸磷酸化和激活来促进三阴性乳腺癌中的生长因子介导的转移。
J Hematol Oncol. 2021 Jan 6;14(1):6. doi: 10.1186/s13045-020-01021-x.
4
Suppression of the USP10/CCND1 axis induces glioblastoma cell apoptosis.抑制 USP10/CCND1 轴可诱导神经胶质瘤细胞凋亡。
Acta Pharmacol Sin. 2021 Aug;42(8):1338-1346. doi: 10.1038/s41401-020-00551-x. Epub 2020 Nov 12.
5
Potential of microRNA based diagnostics and therapeutics in glioma: a patent review.基于 microRNA 的胶质瘤诊断和治疗的潜力:专利述评。
Expert Opin Ther Pat. 2021 Jan;31(1):91-106. doi: 10.1080/13543776.2021.1837775. Epub 2020 Dec 10.
6
LINC00662 sponges miR-107 accelerating the invasiveness and proliferation of glioma cells.LINC00662 通过吸附 miR-107 促进胶质瘤细胞的侵袭和增殖。
J Cancer. 2020 Jul 29;11(19):5700-5712. doi: 10.7150/jca.46381. eCollection 2020.
7
MicroRNA‑34a expression affects breast cancer invasion in vitro and patient survival via downregulation of E2F1 and E2F3 expression.miRNA-34a 的表达通过下调 E2F1 和 E2F3 的表达影响体外乳腺癌侵袭和患者生存。
Oncol Rep. 2020 Jun;43(6):2062-2072. doi: 10.3892/or.2020.7549. Epub 2020 Mar 18.
8
Long non-coding RNAs (lncRNAs) and microRNAs regulatory pathways in the tumorigenesis and pathogenesis of glioma.长链非编码RNA(lncRNAs)和微小RNA在胶质瘤发生发展过程中的调控通路
Discov Med. 2019 Sep;28(153):129-138.
9
Long non-coding RNA FGD5-AS1 promotes non-small cell lung cancer cell proliferation through sponging hsa-miR-107 to up-regulate FGFRL1.长链非编码 RNA FGD5-AS1 通过海绵吸附 hsa-miR-107 来上调 FGFRL1 促进非小细胞肺癌细胞增殖。
Biosci Rep. 2020 Jan 31;40(1). doi: 10.1042/BSR20193309.
10
MiR-107 confers chemoresistance to colorectal cancer by targeting calcium-binding protein 39.miR-107 通过靶向钙结合蛋白 39 赋予结直肠癌细胞化疗耐药性。
Br J Cancer. 2020 Mar;122(5):705-714. doi: 10.1038/s41416-019-0703-3. Epub 2020 Jan 10.